Patents by Inventor Jan Johan Adriaan Tuiten

Jan Johan Adriaan Tuiten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR THE PREPARATION OF DRUG DELIVERY SYSTEMS HAVING A TESTOSTERONE COMPOUND PRESENT IN AN OUTER LAYER OR PART, AS WELL AS SUCH DRUG DELIVERY SYSTEMS
    Publication number: 20230330028
    Abstract: The invention relates to a process for preparing a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a spray coating comprising a testosterone.
    Type: Application
    Filed: June 21, 2023
    Publication date: October 19, 2023
    Applicant: EB IP Hybritabs B.V.
    Inventors: Leonardus Gerardus Jozef DE LEEDE, Henderik Willem FRIJLINK, Mark WILLIAMS, Jan Johan Adriaan TUITEN, Anko Cornelus EISSENS
  • PROCESS FOR THE PREPARATION OF DRUG DELIVERY SYSTEMS HAVING A TESTOSTERONE COMPOUND PRESENT IN AN OUTER LAYER OR PART, AS WELL AS SUCH DRUG DELIVERY SYSTEMS
    Publication number: 20200306195
    Abstract: The invention relates to a process for preparing a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a spray coating comprising a testosterone.
    Type: Application
    Filed: May 23, 2017
    Publication date: October 1, 2020
    Applicant: EB IP Hybritabs B.V.
    Inventors: Leonardus Gerardus Jozef DE LEEDE, Henderik Willem FRIJLINK, Mark WILLIAMS, Jan Johan Adriaan TUITEN, Anko Cornelis EISSENS
  • PHARMACEUTICAL FORMULATIONS AND USES THEREOF IN THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
    Publication number: 20190388435
    Abstract: The present invention relates to the use of a combination of a PDE5-inhibitor and testosterone for the preparation of a medicament for the treatment of Female Sexual Dysfunction.
    Type: Application
    Filed: September 6, 2019
    Publication date: December 26, 2019
    Applicant: EB IP LYBRIDO B.V.
    Inventor: Jan Johan Adriaan TUITEN
  • Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
    Patent number: 10441592
    Abstract: The present invention relates to the use of a combination of a PDE5-inhibitor and testosterone for the preparation of a medicament for the treatment of Female Sexual Dysfunction.
    Type: Grant
    Filed: June 12, 2017
    Date of Patent: October 15, 2019
    Assignee: EB IP LYBRIDO B.V.
    Inventor: Jan Johan Adriaan Tuiten
  • USE OF TESTOSTERONE AND A 5-HT1A AGONIST IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20190262359
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Application
    Filed: May 14, 2019
    Publication date: August 29, 2019
    Applicant: EB IP LYBRIDOS B.V.
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS, Robertus Petrus Johannes DE LANGE
  • Use of testosterone and a 5-HT1A agonist in the treatment of sexual dysfunction
    Patent number: 10314848
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: June 11, 2019
    Assignee: EB IP LYBRIDOS B.V.
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
  • PHARMACEUTICAL FORMULATIONS AND USES THEREOF IN THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
    Publication number: 20170273989
    Abstract: The present invention relates to the use of a combination of a PDE5-inhibitor and testosterone for the preparation of a medicament for the treatment of Female Sexual Dysfunction.
    Type: Application
    Filed: June 12, 2017
    Publication date: September 28, 2017
    Applicant: EB IP LYBRIDO B.V.
    Inventor: Jan Johan Adriaan TUITEN
  • Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
    Patent number: 9737548
    Abstract: The invention relates to the field of female sexual dysfunction. It specifically relates to the influence of the combination of testosterone or an analog thereof and tadalafil on sexual health in female subjects with Female Sexual Dysfunction (such as Female Sexual Arousal Disorder (FSAD) or Female Sexual Desire Disorder (FSDD)). It further relates to the influence of the combination of testosterone or an analog thereof and a compound capable of at least in part inhibiting smooth muscle constriction, for example a compound capable of at least in part inhibiting the adrenergic tone. The invention further discloses other combinatorial therapies in the treatment of Female Sexual Dysfunction.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: August 22, 2017
    Assignee: EB IP LYBRIDO B.V.
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers
  • Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
    Patent number: 9700566
    Abstract: The present invention relates to the use of a combination of a PDE5-inhibitor and testosterone for the preparation of a medicament for the treatment of Female Sexual Dysfunction.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: July 11, 2017
    Assignee: EB IP LYBRIDO B.V.
    Inventor: Jan Johan Adriaan Tuiten
  • USE OF TESTOSTERONE AND A 5-HT1A AGONIST IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20170157142
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Application
    Filed: February 21, 2017
    Publication date: June 8, 2017
    Applicant: EB IP LYBRIDOS B.V.
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS, Robertus Petrus Johannes DE LANGE
  • Use of testosterone and a 5-HT1A agonist in the treatment of sexual dysfunction
    Patent number: 9597335
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: March 21, 2017
    Assignee: EB IP LYBRIDOS B.V.
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
  • PHARMACEUTICAL FORMULATIONS AND USES THEREOF IN THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
    Publication number: 20170042911
    Abstract: The invention relates to the field of female sexual dysfunction. It specifically relates to the influence of the combination of testosterone or an analog thereof and tadalafil on sexual health in female subjects with Female Sexual Dysfunction (such as Female Sexual Arousal Disorder (FSAD) or Female Sexual Desire Disorder (FSDD)). It further relates to the influence of the combination of testosterone or an analog thereof and a compound capable of at least in part inhibiting smooth muscle constriction, for example a compound capable of at least in part inhibiting the adrenergic tone. The invention further discloses other combinatorial therapies in the treatment of Female Sexual Dysfunction.
    Type: Application
    Filed: October 26, 2016
    Publication date: February 16, 2017
    Applicant: EB IP LYBRIDO B.V.
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS
  • METHODS AND PHARMACEUTICAL FORMULATIONS FOR TREATMENT OF SELECTIVE ESTROGEN-RECEPTOR MODULATOR-INDUCED ADVERSE DRUG REACTIONS
    Publication number: 20160279146
    Abstract: The invention related to methods of treatment of an individual suffering from or at risk of suffering from a selective estrogen-receptor modulator (SERM) induced adverse drug reaction. The invention additionally relates to a pharmaceutical dosage form, preferably a tablet, comprising a composition for pulsatile, not-continuous release of a compound or a combination of compounds that stimulate the dopamine and/or the noradrenergic system.
    Type: Application
    Filed: November 11, 2014
    Publication date: September 29, 2016
    Applicant: Limoxifen B.V.
    Inventors: Jan Johan Adriaan TUITEN, Konrad Bernardus Everardus BOCKER, Hans Peter Frederik KOPPESCHAAR
  • PHARMACEUTICAL FORMULATIONS AND USES THEREOF IN THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
    Publication number: 20160213683
    Abstract: The invention relates to the field of female sexual dysfunction. It specifically relates to the influence of the combination of testosterone or an analog thereof and tadalafil on sexual health in female subjects with Female Sexual Dysfunction (such as Female Sexual Arousal Disorder (FSAD) or Female Sexual Desire Disorder (FSDD)). It further relates to the influence of the combination of testosterone or an analog thereof and a compound capable of at least in part inhibiting smooth muscle constriction, for example a compound capable of at least in part inhibiting the adrenergic tone. The invention further discloses other combinatorial therapies in the treatment of Female Sexual Dysfunction.
    Type: Application
    Filed: April 1, 2016
    Publication date: July 28, 2016
    Applicant: EB IP LYBRIDO B.V.
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS
  • USE OF TESTOSTERONE AND A 5-HT1A AGONIST IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20160082018
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Application
    Filed: December 4, 2015
    Publication date: March 24, 2016
    Applicant: EMOTIONAL BRAIN B.V.
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS, Robertus Petrus Johannes DE LANGE
  • PHARMACEUTICAL FORMULATIONS AND USES THEREOF IN THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
    Publication number: 20160015720
    Abstract: The present invention relates to the use of a combination of a PDE5-inhibitor and testosterone for the preparation of a medicament for the treatment of Female Sexual Dysfunction.
    Type: Application
    Filed: September 25, 2015
    Publication date: January 21, 2016
    Applicant: EB IP LYBRIDO B.V.
    Inventor: Jan Johan Adriaan TUITEN
  • Use of testosterone and a 5-HT1A agonist in the treatment of sexual dysfunction
    Patent number: 9211334
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: December 15, 2015
    Assignee: EB IP LYBRIDOS B.V.
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
  • Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
    Patent number: 9192669
    Abstract: The present invention relates to the use of a combination of a PDE5-inhibitor and testosterone for the preparation of a medicament for the treatment of Female Sexual Dysfunction.
    Type: Grant
    Filed: June 21, 2012
    Date of Patent: November 24, 2015
    Assignee: EB IP LYBRIDO B.V.
    Inventor: Jan Johan Adriaan Tuiten
  • USE OF 3-ALPHA-ANDROSTANEDIOL, OPTIONALLY IN COMBINATION WITH A PDE5 INHIBITOR, IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20140121190
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of 3-alpha-androstanediol, preferably in combination with a type 5 phosphodiesterase (PDE5) inhibitor.
    Type: Application
    Filed: January 3, 2014
    Publication date: May 1, 2014
    Applicant: EMOTIONAL BRAIN B.V.
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS, Robertus Petrus Johannes DE LANGE
  • USE OF 3-ALPHA-ANDROSTANEDIOL, OPTIONALLY IN COMBINATION WITH A 5-HT1A AGONIST, IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20140121189
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of 3-alpha-androstanediol, preferably in combination with a 5-HT1A agonist. Optionally, said 3-alpha-androstanediol and said 5HT1a agonist are further combined with a type 5 phosphodiesterase (PDE5) inhibitor.
    Type: Application
    Filed: January 3, 2014
    Publication date: May 1, 2014
    Applicant: EMOTIONAL BRAIN B.V.
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS, Robertus Petrus Johannes DE LANGE